PaoloCotziaMD

Summary

• Board-certified clinical, anatomic and molecular genetic pathologist, sub-specialized in oncologic surgical pathology and molecular genetics. Experience in biomarker discovery, molecular diagnostic assays development, digital pathology, A.I., biobanking, clinical trials and design of correlative studies.
  Medical Director for Molecular Pathology, overseeing operations at next generation molecular, ThyroSeq laboratory, in Rye Brook, New York.
  Head of the SHUSA Molecular Pathology Center of Excellence, hub for high-throughput genomic analysis enhancing and expanding molecular diagnostics across Sonic Healthcare USA network.
  Member of the College of American Pathologists, United States and Canadian Academy of Pathology, and Fellow of the American Society for Clinical Pathology.
  Committed to advancing excellence in patient care through novel medical technology.